NCT02132442View on ClinicalTrials.gov

Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Type 2 DiabetesNonalcoholic Fatty Liver DiseaseVitamin D Deficiency
Interventions
DIETARY_SUPPLEMENT

Ergocalciferol, placebo

Ergocalciferol 50000 IU capsules Microcrystalline cellulose

Trial Locations (1)

01609

University of Massachusetts Medical School, Worcester

All Listed Sponsors
lead

University of Massachusetts, Worcester

OTHER

NCT02132442 - Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes | Biotech Hunter | Biotech Hunter